Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prokidney (PROK) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to -$35.8 million.

  • Prokidney's Net Income towards Common Stockholders rose 1269.09% to -$35.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$159.2 million, marking a year-over-year decrease of 1659.66%. This contributed to the annual value of -$61.2 million for FY2024, which is 7251.04% down from last year.
  • As of Q3 2025, Prokidney's Net Income towards Common Stockholders stood at -$35.8 million, which was up 1269.09% from -$37.0 million recorded in Q2 2025.
  • In the past 5 years, Prokidney's Net Income towards Common Stockholders registered a high of -$14.4 million during Q4 2022, and its lowest value of -$67.5 million during Q1 2022.
  • In the last 4 years, Prokidney's Net Income towards Common Stockholders had a median value of -$36.9 million in 2023 and averaged -$36.5 million.
  • Per our database at Business Quant, Prokidney's Net Income towards Common Stockholders skyrocketed by 4530.87% in 2023 and then tumbled by 12317.71% in 2024.
  • Quarter analysis of 4 years shows Prokidney's Net Income towards Common Stockholders stood at -$14.4 million in 2022, then crashed by 50.86% to -$21.7 million in 2023, then tumbled by 123.18% to -$48.5 million in 2024, then increased by 26.07% to -$35.8 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$35.8 million for Q3 2025, versus -$37.0 million for Q2 2025 and -$38.0 million for Q1 2025.